
Catherine Serke Williams
Examiner (ID: 6974, Phone: (571)272-4970 , Office: P/3993 )
| Most Active Art Unit | 3763 |
| Art Unit(s) | 3763, 3762, 3731, 3993 |
| Total Applications | 1016 |
| Issued Applications | 626 |
| Pending Applications | 245 |
| Abandoned Applications | 163 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 15129911
[patent_doc_number] => 10478392
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2019-11-19
[patent_title] => Peptide and cosmetic composition comprising same for preventing skin aging or skin wrinkle formation
[patent_app_type] => utility
[patent_app_number] => 15/771222
[patent_app_country] => US
[patent_app_date] => 2016-10-27
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 4
[patent_figures_cnt] => 4
[patent_no_of_words] => 1985
[patent_no_of_claims] => 5
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 16
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15771222
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/771222 | Peptide and cosmetic composition comprising same for preventing skin aging or skin wrinkle formation | Oct 26, 2016 | Issued |
Array
(
[id] => 13479087
[patent_doc_number] => 20180291086
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2018-10-11
[patent_title] => LIPOPLEXES FORMULATED FOR CATALYTIC DELIVERY
[patent_app_type] => utility
[patent_app_number] => 15/766088
[patent_app_country] => US
[patent_app_date] => 2016-10-05
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 18078
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -18
[patent_words_short_claim] => 26
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15766088
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/766088 | LIPOPLEXES FORMULATED FOR CATALYTIC DELIVERY | Oct 4, 2016 | Abandoned |
Array
(
[id] => 11750376
[patent_doc_number] => 09708378
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2017-07-18
[patent_title] => 'Peptides derived from NCAPG2 and their use'
[patent_app_type] => utility
[patent_app_number] => 15/285873
[patent_app_country] => US
[patent_app_date] => 2016-10-05
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 38
[patent_figures_cnt] => 44
[patent_no_of_words] => 10894
[patent_no_of_claims] => 3
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 56
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15285873
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/285873 | Peptides derived from NCAPG2 and their use | Oct 4, 2016 | Issued |
Array
(
[id] => 11400258
[patent_doc_number] => 20170020797
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2017-01-26
[patent_title] => 'COMPOSITION'
[patent_app_type] => utility
[patent_app_number] => 15/284586
[patent_app_country] => US
[patent_app_date] => 2016-10-04
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 3
[patent_figures_cnt] => 3
[patent_no_of_words] => 6449
[patent_no_of_claims] => 6
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15284586
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/284586 | Composition | Oct 3, 2016 | Issued |
Array
(
[id] => 14594177
[patent_doc_number] => 10350265
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2019-07-16
[patent_title] => Therapeutic applications of Smad7
[patent_app_type] => utility
[patent_app_number] => 15/282022
[patent_app_country] => US
[patent_app_date] => 2016-09-30
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 8
[patent_figures_cnt] => 8
[patent_no_of_words] => 13447
[patent_no_of_claims] => 17
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 77
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15282022
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/282022 | Therapeutic applications of Smad7 | Sep 29, 2016 | Issued |
Array
(
[id] => 11400422
[patent_doc_number] => 20170020960
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2017-01-26
[patent_title] => 'LIQUID FORMULATIONS OF TUMOR NECROSIS FACTOR-BINDING PROTEINS'
[patent_app_type] => utility
[patent_app_number] => 15/283001
[patent_app_country] => US
[patent_app_date] => 2016-09-30
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 7
[patent_figures_cnt] => 7
[patent_no_of_words] => 4106
[patent_no_of_claims] => 10
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15283001
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/283001 | LIQUID FORMULATIONS OF TUMOR NECROSIS FACTOR-BINDING PROTEINS | Sep 29, 2016 | Abandoned |
Array
(
[id] => 13461681
[patent_doc_number] => 20180282383
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2018-10-04
[patent_title] => SMALL MOLECULES BLOCKING HISTONE READER DOMAINS
[patent_app_type] => utility
[patent_app_number] => 15/765344
[patent_app_country] => US
[patent_app_date] => 2016-09-30
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 22180
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -16
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15765344
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/765344 | SMALL MOLECULES BLOCKING HISTONE READER DOMAINS | Sep 29, 2016 | Abandoned |
Array
(
[id] => 16604654
[patent_doc_number] => 10905637
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2021-02-02
[patent_title] => Peptide nanoparticles and uses therefor
[patent_app_type] => utility
[patent_app_number] => 15/279687
[patent_app_country] => US
[patent_app_date] => 2016-09-29
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 1
[patent_figures_cnt] => 1
[patent_no_of_words] => 17256
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 149
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15279687
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/279687 | Peptide nanoparticles and uses therefor | Sep 28, 2016 | Issued |
Array
(
[id] => 16198634
[patent_doc_number] => 10723784
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2020-07-28
[patent_title] => Compositions and methods for preparing a subject for organ or non-organ implantation
[patent_app_type] => utility
[patent_app_number] => 15/279258
[patent_app_country] => US
[patent_app_date] => 2016-09-28
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 38
[patent_figures_cnt] => 38
[patent_no_of_words] => 14121
[patent_no_of_claims] => 31
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 63
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15279258
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/279258 | Compositions and methods for preparing a subject for organ or non-organ implantation | Sep 27, 2016 | Issued |
Array
(
[id] => 13885505
[patent_doc_number] => 10195284
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2019-02-05
[patent_title] => Compositions and methods for controlled localized delivery of bone forming therapeutic agents
[patent_app_type] => utility
[patent_app_number] => 15/276382
[patent_app_country] => US
[patent_app_date] => 2016-09-26
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 60
[patent_figures_cnt] => 88
[patent_no_of_words] => 40522
[patent_no_of_claims] => 38
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 41
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15276382
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/276382 | Compositions and methods for controlled localized delivery of bone forming therapeutic agents | Sep 25, 2016 | Issued |
Array
(
[id] => 13805083
[patent_doc_number] => 10179803
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2019-01-15
[patent_title] => Methods for inhibiting immune complex formation in a subject
[patent_app_type] => utility
[patent_app_number] => 15/269537
[patent_app_country] => US
[patent_app_date] => 2016-09-19
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 16
[patent_figures_cnt] => 10
[patent_no_of_words] => 18677
[patent_no_of_claims] => 4
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 13
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15269537
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/269537 | Methods for inhibiting immune complex formation in a subject | Sep 18, 2016 | Issued |
Array
(
[id] => 11628761
[patent_doc_number] => 20170138950
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2017-05-18
[patent_title] => 'IDENTIFICATION OF CANCER PROTEIN BIOMARKERS USING PROTEOMIC TECHNIQUES'
[patent_app_type] => utility
[patent_app_number] => 15/268134
[patent_app_country] => US
[patent_app_date] => 2016-09-16
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 7
[patent_figures_cnt] => 7
[patent_no_of_words] => 16800
[patent_no_of_claims] => 13
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15268134
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/268134 | Identification of cancer protein biomarkers using proteomic techniques | Sep 15, 2016 | Issued |
Array
(
[id] => 11348900
[patent_doc_number] => 20160367640
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2016-12-22
[patent_title] => 'RAPID-ACTING INSULIN COMPOSITIONS'
[patent_app_type] => utility
[patent_app_number] => 15/259101
[patent_app_country] => US
[patent_app_date] => 2016-09-08
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 8068
[patent_no_of_claims] => 21
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15259101
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/259101 | Rapid-acting insulin compositions | Sep 7, 2016 | Issued |
Array
(
[id] => 15281781
[patent_doc_number] => 10513545
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2019-12-24
[patent_title] => Fusion polypeptide in which anti-inflammatory polypeptide and ferritin monomer fragment are bound and pharmaceutical composition for preventing and treating inflammatory diseases, containing same as active ingredient
[patent_app_type] => utility
[patent_app_number] => 15/757580
[patent_app_country] => US
[patent_app_date] => 2016-09-02
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 19
[patent_figures_cnt] => 32
[patent_no_of_words] => 11866
[patent_no_of_claims] => 8
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 19
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15757580
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/757580 | Fusion polypeptide in which anti-inflammatory polypeptide and ferritin monomer fragment are bound and pharmaceutical composition for preventing and treating inflammatory diseases, containing same as active ingredient | Sep 1, 2016 | Issued |
Array
(
[id] => 12198575
[patent_doc_number] => 09901623
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2018-02-27
[patent_title] => 'Rapid-acting insulin compositions'
[patent_app_type] => utility
[patent_app_number] => 15/241412
[patent_app_country] => US
[patent_app_date] => 2016-08-19
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 17298
[patent_no_of_claims] => 31
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 59
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15241412
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/241412 | Rapid-acting insulin compositions | Aug 18, 2016 | Issued |
Array
(
[id] => 11668476
[patent_doc_number] => 20170157196
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2017-06-08
[patent_title] => 'PEPTIDE FRAGMENTS FOR INDUCING SYNTHESIS OF EXTRACELLULAR MATRIX PROTEINS'
[patent_app_type] => utility
[patent_app_number] => 15/239708
[patent_app_country] => US
[patent_app_date] => 2016-08-17
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 4
[patent_figures_cnt] => 4
[patent_no_of_words] => 7585
[patent_no_of_claims] => 10
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15239708
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/239708 | Peptide fragments for inducing synthesis of extracellular matrix proteins | Aug 16, 2016 | Issued |
Array
(
[id] => 11289119
[patent_doc_number] => 20160339050
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2016-11-24
[patent_title] => 'Methods of Treating, Reducing the Incidence of, and/or Preventing Ischemic Events'
[patent_app_type] => utility
[patent_app_number] => 15/225886
[patent_app_country] => US
[patent_app_date] => 2016-08-02
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 15
[patent_figures_cnt] => 15
[patent_no_of_words] => 22281
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15225886
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/225886 | Methods of treating, reducing the incidence of, and/or preventing ischemic events | Aug 1, 2016 | Issued |
Array
(
[id] => 13026449
[patent_doc_number] => 10035840
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2018-07-31
[patent_title] => Targeted coagulation factors and method of using the same
[patent_app_type] => utility
[patent_app_number] => 15/222001
[patent_app_country] => US
[patent_app_date] => 2016-07-28
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 7
[patent_figures_cnt] => 7
[patent_no_of_words] => 7914
[patent_no_of_claims] => 15
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 62
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15222001
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/222001 | Targeted coagulation factors and method of using the same | Jul 27, 2016 | Issued |
Array
(
[id] => 13793325
[patent_doc_number] => 20190010201
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2019-01-10
[patent_title] => Polypeptide for Inhibition of Tumor
[patent_app_type] => utility
[patent_app_number] => 15/746978
[patent_app_country] => US
[patent_app_date] => 2016-07-21
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 10918
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -19
[patent_words_short_claim] => 142
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15746978
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/746978 | Polypeptide for inhibition of tumor | Jul 20, 2016 | Issued |
Array
(
[id] => 11362862
[patent_doc_number] => 20170000844
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2017-01-05
[patent_title] => 'Treatment of Ascites'
[patent_app_type] => utility
[patent_app_number] => 15/198050
[patent_app_country] => US
[patent_app_date] => 2016-06-30
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 3118
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15198050
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/198050 | Treatment of ascites | Jun 29, 2016 | Issued |